• ورود به سامانه
      مشاهده مورد 
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Pharmaceutical Research
      • Volume 16, Issue 4
      • مشاهده مورد
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Pharmaceutical Research
      • Volume 16, Issue 4
      • مشاهده مورد
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      Screening for Type II L-Asparaginases: Lessons from the Genus Halomonas

      (ندگان)پدیدآور
      Sharafi, ZeinabBarati, MahmoodKhoshayand, MohammadrezaAdrangi, Sina
      Thumbnail
      دریافت مدرک مشاهده
      FullText
      اندازه فایل: 
      448.9کیلوبایت
      نوع فايل (MIME): 
      PDF
      نوع مدرک
      Text
      Research article
      زبان مدرک
      English
      نمایش کامل رکورد
      چکیده
      Among the two types of bacterial L-asparaginases, only type II enzymes have been used inthe treatment of acute lymphoblastic leukemia owing to their higher affinity for L-asparagine.However, current screening media used for the isolation of L-asparaginase-producingmicroorganisms do not discriminate between the two types of L-asparaginase. During anoptimization study conducted to increase L-asparaginase production by environmentalHalomonas isolates, it was noticed that the pattern of L-asparaginase production in responseto variations in glucose concentration varied between different isolates suggesting that theydiffer in their ability to produce type II L-asparaginases, an observation that was confirmed byfurther experiments. Bioinformatics analysis of available Halomonas whole genome sequencesrevealed that indeed some species of this genus possess both L-asparaginase types while otherspossess only type I enzymes. By comparing the growth pattern of these isolates on differentmedia, we propose that by omitting glucose, reducing the concentration of L-asparagine andproviding an alternative nitrogen source in L-asparaginase screening media it may be possibleto differentiate between type I and type II activities.
      کلید واژگان
      Screening
      L-asparaginase
      Halomonas
      Oligotrophy
      optimization
      Pharmacutical biotechnology

      شماره نشریه
      4
      تاریخ نشر
      2017-11-01
      1396-08-10
      ناشر
      School of Pharmacy, Shahid Beheshti University of Medical Sciences
      سازمان پدید آورنده
      Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
      Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
      Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
      Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

      شاپا
      1735-0328
      1726-6890
      URI
      https://dx.doi.org/10.22037/ijpr.2017.2145
      http://ijpr.sbmu.ac.ir/article_2145.html
      https://iranjournals.nlai.ir/handle/123456789/313637

      مرور

      همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

      حساب من

      ورود به سامانهثبت نام

      تازه ترین ها

      تازه ترین مدارک
      © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
      تماس با ما | ارسال بازخورد
      قدرت یافته توسطسیناوب